APO Research
Talk to an analyst

APO RESEARCH · REPORT

FAPI for Tumor Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global FAPI for Tumor Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025185 pages

Choose your research edition.

Industry ResearchFAPI for Tumor Diagnosis Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal FAPI for Tumor Diagnosis Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal FAPI for Tumor Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal FAPI for Tumor Diagnosis Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal FAPI for Tumor Diagnosis Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global FAPI for Tumor Diagnosis market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for FAPI for Tumor Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for FAPI for Tumor Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for FAPI for Tumor Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for FAPI for Tumor Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of FAPI for Tumor Diagnosis include SOFIE, Ferronova, GE HealthCare, Isotopia and Lantheus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global FAPI for Tumor Diagnosis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of FAPI for Tumor Diagnosis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents FAPI for Tumor Diagnosis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the FAPI for Tumor Diagnosis market size, projected growth trends, production technologies, key applications, and end-use industries.

FAPI for Tumor Diagnosis Segment by Company

SOFIE

Ferronova

GE HealthCare

Isotopia

Lantheus

FAPI for Tumor Diagnosis Segment by Type

Ga-labeled

F-labeled

Other

FAPI for Tumor Diagnosis Segment by Application

NSCLC

Pancreatic Cancer

Breast Cancer

Others

FAPI for Tumor Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global FAPI for Tumor Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of FAPI for Tumor Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of FAPI for Tumor Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the FAPI for Tumor Diagnosis market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of FAPI for Tumor Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of FAPI for Tumor Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of FAPI for Tumor Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. FAPI for Tumor Diagnosis Industry Trends Table 2. FAPI for Tumor Diagnosis Industry Drivers Table 3. FAPI for Tumor Diagnosis Industry Opportunities and Challenges Table 4. FAPI for Tumor Diagnosis Industry Restraints Table 5. Global FAPI for Tumor Diagnosis Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global FAPI for Tumor Diagnosis Revenue Market Share by Manufacturers (2021-2026) Table 7. Global FAPI for Tumor Diagnosis Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global FAPI for Tumor Diagnosis Sales Market Share by Manufacturers Table 9. Global FAPI for Tumor Diagnosis Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global FAPI for Tumor Diagnosis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global FAPI for Tumor Diagnosis Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global FAPI for Tumor Diagnosis Manufacturers, Product Type & Application Table 13. Global FAPI for Tumor Diagnosis Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global FAPI for Tumor Diagnosis by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ga-labeled Table 17. Major Manufacturers of F-labeled Table 18. Major Manufacturers of Other Table 19. Global FAPI for Tumor Diagnosis Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global FAPI for Tumor Diagnosis Sales by Type (2021-2026) & (K Units) Table 21. Global FAPI for Tumor Diagnosis Sales by Type (2027-2032) & (K Units) Table 22. Global FAPI for Tumor Diagnosis Sales Market Share by Type (2021-2026) Table 23. Global FAPI for Tumor Diagnosis Sales Market Share by Type (2027-2032) Table 24. Global FAPI for Tumor Diagnosis Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global FAPI for Tumor Diagnosis Revenue by Type (2021-2026) & (K Units) Table 26. Global FAPI for Tumor Diagnosis Revenue by Type (2027-2032) & (K Units) Table 27. Global FAPI for Tumor Diagnosis Revenue Market Share by Type (2021-2026) Table 28. Global FAPI for Tumor Diagnosis Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of NSCLC Table 30. Major Manufacturers of Pancreatic Cancer Table 31. Major Manufacturers of Breast Cancer Table 32. Major Manufacturers of Others Table 33. Global FAPI for Tumor Diagnosis Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global FAPI for Tumor Diagnosis Sales by Application (2021-2026) & (K Units) Table 35. Global FAPI for Tumor Diagnosis Sales by Application (2027-2032) & (K Units) Table 36. Global FAPI for Tumor Diagnosis Sales Market Share by Application (2021-2026) Table 37. Global FAPI for Tumor Diagnosis Sales Market Share by Application (2027-2032) Table 38. Global FAPI for Tumor Diagnosis Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global FAPI for Tumor Diagnosis Revenue by Application (2021-2026) & (K Units) Table 40. Global FAPI for Tumor Diagnosis Revenue by Application (2027-2032) & (K Units) Table 41. Global FAPI for Tumor Diagnosis Revenue Market Share by Application (2021-2026) Table 42. Global FAPI for Tumor Diagnosis Revenue Market Share by Application (2027-2032) Table 43. Global FAPI for Tumor Diagnosis Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global FAPI for Tumor Diagnosis Sales by Region (2021-2026) & (K Units) Table 45. Global FAPI for Tumor Diagnosis Sales Market Share by Region (2021-2026) Table 46. Global FAPI for Tumor Diagnosis Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global FAPI for Tumor Diagnosis Sales Forecasted Market Share by Region (2027-2032) Table 48. North America FAPI for Tumor Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America FAPI for Tumor Diagnosis Sales by Country (2021-2026) & (K Units) Table 50. North America FAPI for Tumor Diagnosis Sales by Country (2027-2032) & (K Units) Table 51. Europe FAPI for Tumor Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe FAPI for Tumor Diagnosis Sales by Country (2021-2026) & (K Units) Table 53. Europe FAPI for Tumor Diagnosis Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific FAPI for Tumor Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific FAPI for Tumor Diagnosis Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific FAPI for Tumor Diagnosis Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa FAPI for Tumor Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa FAPI for Tumor Diagnosis Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa FAPI for Tumor Diagnosis Sales by Country (2027-2032) & (K Units) Table 60. Global FAPI for Tumor Diagnosis Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global FAPI for Tumor Diagnosis Revenue by Region (2021-2026) & (US$ Million) Table 62. Global FAPI for Tumor Diagnosis Revenue by Region (2027-2032) & (US$ Million) Table 63. Global FAPI for Tumor Diagnosis Revenue Market Share by Region (2021-2026) Table 64. Global FAPI for Tumor Diagnosis Revenue Market Share by Region (2027-2032) Table 65. SOFIE Company Information Table 66. SOFIE Business Overview Table 67. SOFIE FAPI for Tumor Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. SOFIE FAPI for Tumor Diagnosis Product Portfolio Table 69. SOFIE Recent Development Table 70. Ferronova Company Information Table 71. Ferronova Business Overview Table 72. Ferronova FAPI for Tumor Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Ferronova FAPI for Tumor Diagnosis Product Portfolio Table 74. Ferronova Recent Development Table 75. GE HealthCare Company Information Table 76. GE HealthCare Business Overview Table 77. GE HealthCare FAPI for Tumor Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. GE HealthCare FAPI for Tumor Diagnosis Product Portfolio Table 79. GE HealthCare Recent Development Table 80. Isotopia Company Information Table 81. Isotopia Business Overview Table 82. Isotopia FAPI for Tumor Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Isotopia FAPI for Tumor Diagnosis Product Portfolio Table 84. Isotopia Recent Development Table 85. Lantheus Company Information Table 86. Lantheus Business Overview Table 87. Lantheus FAPI for Tumor Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Lantheus FAPI for Tumor Diagnosis Product Portfolio Table 89. Lantheus Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. FAPI for Tumor Diagnosis Distributors List Table 93. FAPI for Tumor Diagnosis Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. FAPI for Tumor Diagnosis Product Image Figure 2. Global FAPI for Tumor Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global FAPI for Tumor Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global FAPI for Tumor Diagnosis Sales (2021-2032) & (K Units) Figure 5. Global FAPI for Tumor Diagnosis Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 FAPI for Tumor Diagnosis Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ga-labeled Image Figure 9. F-labeled Image Figure 10. Other Image Figure 11. Global FAPI for Tumor Diagnosis Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global FAPI for Tumor Diagnosis Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global FAPI for Tumor Diagnosis Sales Market Share by Type (2021-2032) Figure 14. Global FAPI for Tumor Diagnosis Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global FAPI for Tumor Diagnosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global FAPI for Tumor Diagnosis Revenue Market Share by Type (2021-2032) Figure 17. NSCLC Image Figure 18. Pancreatic Cancer Image Figure 19. Breast Cancer Image Figure 20. Others Image Figure 21. Global FAPI for Tumor Diagnosis Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global FAPI for Tumor Diagnosis Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global FAPI for Tumor Diagnosis Sales Market Share by Application (2021-2032) Figure 24. Global FAPI for Tumor Diagnosis Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global FAPI for Tumor Diagnosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global FAPI for Tumor Diagnosis Revenue Market Share by Application (2021-2032) Figure 27. North America FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America FAPI for Tumor Diagnosis Sales Market Share by Country (2021-2032) Figure 29. U.S. FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe FAPI for Tumor Diagnosis Sales Market Share by Country (2021-2032) Figure 34. Germany FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific FAPI for Tumor Diagnosis Sales Market Share by Country (2021-2032) Figure 41. China FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa FAPI for Tumor Diagnosis Sales Market Share by Country (2021-2032) Figure 49. Brazil FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile FAPI for Tumor Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global FAPI for Tumor Diagnosis Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global FAPI for Tumor Diagnosis Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America FAPI for Tumor Diagnosis Revenue (2021-2032) & (US$ Million) Figure 60. North America FAPI for Tumor Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe FAPI for Tumor Diagnosis Revenue (2021-2032) & (US$ Million) Figure 62. Europe FAPI for Tumor Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific FAPI for Tumor Diagnosis Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific FAPI for Tumor Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa FAPI for Tumor Diagnosis Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa FAPI for Tumor Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. FAPI for Tumor Diagnosis Value Chain Figure 68. Manufacturing Cost Structure Figure 69. FAPI for Tumor Diagnosis Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Ga-labeled
  • F-labeled
  • Other
Applications
  • NSCLC
  • Pancreatic Cancer
  • Breast Cancer
  • Others
Companies covered
  • SOFIE
  • Ferronova
  • GE HealthCare
  • Isotopia
  • Lantheus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global FAPI for Tumor Diagnosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global FAPI for Tumor Diagnosis Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global FAPI for Tumor Diagnosis Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global FAPI for Tumor Diagnosis Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global FAPI for Tumor Diagnosis Market Dynamics
  1. 2.1 FAPI for Tumor Diagnosis Industry Trends
  2. 2.2 FAPI for Tumor Diagnosis Industry Drivers
  3. 2.3 FAPI for Tumor Diagnosis Industry Opportunities and Challenges
  4. 2.4 FAPI for Tumor Diagnosis Industry Restraints
3 FAPI for Tumor Diagnosis Market by Manufacturers
  1. 3.1 Global FAPI for Tumor Diagnosis Revenue by Manufacturers (2021-2026)
  2. 3.2 Global FAPI for Tumor Diagnosis Sales by Manufacturers (2021-2026)
  3. 3.3 Global FAPI for Tumor Diagnosis Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global FAPI for Tumor Diagnosis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global FAPI for Tumor Diagnosis Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global FAPI for Tumor Diagnosis Manufacturers, Product Type & Application
  7. 3.7 Global FAPI for Tumor Diagnosis Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global FAPI for Tumor Diagnosis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 FAPI for Tumor Diagnosis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 FAPI for Tumor Diagnosis Tier 1, Tier 2, and Tier 3
4 FAPI for Tumor Diagnosis Market by Type
  1. 4.1 FAPI for Tumor Diagnosis Type Introduction
  2. 4.1.1 Ga-labeled
  3. 4.1.2 F-labeled
  4. 4.1.3 Other
  5. 4.2 Global FAPI for Tumor Diagnosis Sales by Type
  6. 4.2.1 Global FAPI for Tumor Diagnosis Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global FAPI for Tumor Diagnosis Sales by Type (2021-2032)
  8. 4.2.3 Global FAPI for Tumor Diagnosis Sales Market Share by Type (2021-2032)
  9. 4.3 Global FAPI for Tumor Diagnosis Revenue by Type
  10. 4.3.1 Global FAPI for Tumor Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global FAPI for Tumor Diagnosis Revenue by Type (2021-2032)
  12. 4.3.3 Global FAPI for Tumor Diagnosis Revenue Market Share by Type (2021-2032)
5 FAPI for Tumor Diagnosis Market by Application
  1. 5.1 FAPI for Tumor Diagnosis Application Introduction
  2. 5.1.1 NSCLC
  3. 5.1.2 Pancreatic Cancer
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Others
  6. 5.2 Global FAPI for Tumor Diagnosis Sales by Application
  7. 5.2.1 Global FAPI for Tumor Diagnosis Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global FAPI for Tumor Diagnosis Sales by Application (2021-2032)
  9. 5.2.3 Global FAPI for Tumor Diagnosis Sales Market Share by Application (2021-2032)
  10. 5.3 Global FAPI for Tumor Diagnosis Revenue by Application
  11. 5.3.1 Global FAPI for Tumor Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global FAPI for Tumor Diagnosis Revenue by Application (2021-2032)
  13. 5.3.3 Global FAPI for Tumor Diagnosis Revenue Market Share by Application (2021-2032)
6 Global FAPI for Tumor Diagnosis Sales by Region
  1. 6.1 Global FAPI for Tumor Diagnosis Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global FAPI for Tumor Diagnosis Sales by Region (2021-2032)
  3. 6.2.1 Global FAPI for Tumor Diagnosis Sales by Region (2021-2026)
  4. 6.2.2 Global FAPI for Tumor Diagnosis Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America FAPI for Tumor Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America FAPI for Tumor Diagnosis Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe FAPI for Tumor Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe FAPI for Tumor Diagnosis Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific FAPI for Tumor Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific FAPI for Tumor Diagnosis Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa FAPI for Tumor Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa FAPI for Tumor Diagnosis Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global FAPI for Tumor Diagnosis Revenue by Region
  1. 7.1 Global FAPI for Tumor Diagnosis Revenue by Region
  2. 7.1.1 Global FAPI for Tumor Diagnosis Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global FAPI for Tumor Diagnosis Revenue by Region (2021-2026)
  4. 7.1.3 Global FAPI for Tumor Diagnosis Revenue by Region (2027-2032)
  5. 7.1.4 Global FAPI for Tumor Diagnosis Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America FAPI for Tumor Diagnosis Revenue (2021-2032)
  8. 7.2.2 North America FAPI for Tumor Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe FAPI for Tumor Diagnosis Revenue (2021-2032)
  11. 7.3.2 Europe FAPI for Tumor Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific FAPI for Tumor Diagnosis Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific FAPI for Tumor Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa FAPI for Tumor Diagnosis Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa FAPI for Tumor Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 SOFIE
  2. 8.1.1 SOFIE Company Information
  3. 8.1.2 SOFIE Business Overview
  4. 8.1.3 SOFIE FAPI for Tumor Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SOFIE FAPI for Tumor Diagnosis Product Portfolio
  6. 8.1.5 SOFIE Recent Developments
  7. 8.2 Ferronova
  8. 8.2.1 Ferronova Company Information
  9. 8.2.2 Ferronova Business Overview
  10. 8.2.3 Ferronova FAPI for Tumor Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ferronova FAPI for Tumor Diagnosis Product Portfolio
  12. 8.2.5 Ferronova Recent Developments
  13. 8.3 GE HealthCare
  14. 8.3.1 GE HealthCare Company Information
  15. 8.3.2 GE HealthCare Business Overview
  16. 8.3.3 GE HealthCare FAPI for Tumor Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GE HealthCare FAPI for Tumor Diagnosis Product Portfolio
  18. 8.3.5 GE HealthCare Recent Developments
  19. 8.4 Isotopia
  20. 8.4.1 Isotopia Company Information
  21. 8.4.2 Isotopia Business Overview
  22. 8.4.3 Isotopia FAPI for Tumor Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Isotopia FAPI for Tumor Diagnosis Product Portfolio
  24. 8.4.5 Isotopia Recent Developments
  25. 8.5 Lantheus
  26. 8.5.1 Lantheus Company Information
  27. 8.5.2 Lantheus Business Overview
  28. 8.5.3 Lantheus FAPI for Tumor Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lantheus FAPI for Tumor Diagnosis Product Portfolio
  30. 8.5.5 Lantheus Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 FAPI for Tumor Diagnosis Value Chain Analysis
  2. 9.1.1 FAPI for Tumor Diagnosis Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 FAPI for Tumor Diagnosis Production Mode & Process
  6. 9.2 FAPI for Tumor Diagnosis Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 FAPI for Tumor Diagnosis Distributors
  9. 9.2.3 FAPI for Tumor Diagnosis Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst